Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Deep brain stimulation is a surgical procedure used for the management of motor function symptoms in patients suffering from various neurological disorders, such as essential tremor, Parkinson’s disease and dystonia, wherein drug therapy is not effective.

The global deep brain stimulation devices market for Parkinson’s disease is estimated to be valued at US$ 3,567.6 million in 2021 and is expected to exhibit a CAGR of 8.3 % over the forecast period (2021-2028).

Recent Developments:

Companies are launching new deep brain stimulation devices based on new and advanced technology which can be attributed to the growth of deep brain stimulation devices market for Parkinson’s disease. For instance, in January 2021, Medtronic plc. announced the first enrollment in Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD). The clinical trials are for testing the safety and efficacy of the Percept PC device which helps in automated adjustment of brain stimulation for providing therapy and management of symptoms associated with Parkinson's disease.

In addition, the technological advancements in deep brain stimulation devices is further boosting the market growth. For instance, in March 2021, University of Houston biomedical engineer presented evidence in Nature Communications Biology that stimulation of higher frequencies (>100Hz) can induce resonating waveforms for recalibration of dysfunctional circuits. This new technology can help in treatment of Parkinson’s disease.

North America held dominant position in the global deep brain stimulation devices market for Parkinson’s disease in 2020, accounting for 37.5% share in terms of volume, followed by Europe and Asia Pacific, respectively. The rapid adoption of new deep brain stimulation devices in the region can be attributed to the market growth. For instance, in June 2021, the University of Florida Health neurosurgeons implanted Medtronic’s SenSight Directional Lead System in Parkinson’s disease patient. It is a technologically advanced deep brain stimulation system for monitoring real-time brain signals.

Figure 1. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Value (US$ Mn), by Region, 2020

Deep Brain Stimulation Devices  | Coherent Market Insights

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Drivers

Increasing prevalence of Parkinson’s disease is expected to propel growth of the global deep brain stimulation devices market for Parkinson’s disease over the forecast period. For instance, according to the study, ‘Prevalence of Parkinson’s disease (PD) across North America”, published in July 2018 in the journal Nature, the number of people suffering from PD is expected to reach 930,000 in 2020 and 1,238,000 in 2030.   

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

request-sample

Deep Brain Stimulation Devices Market for Parkinson’s Disease Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 3,567.6 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 8.3% 2028 Value Projection: US$ 6,234.3 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product: Single Channel, Dual-Channel
Companies covered:

Boston Scientific Corporation, MEDTRONIC, Inc., St Jude Medical, Inc., Sapiens Neuro, and Aleva Neurotherapeutics SA

Growth Drivers:
  • Increasing prevalence of Parkinson’s disease
  • Increasing geriatric population
Restraints & Challenges:
  • Excise tax on medical devices
  • Use of deep brain stimulation limited to highly refractory patients and conditions

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Opportunities 

Benefits of deep brain stimulation over other approaches is expected to offer lucrative growth opportunities for players in the global deep brain stimulation devices market for Parkinson’s disease. For instance, in June 2020, the study, ‘Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Five Year Outcomes’, published in Neurology, reported that deep brain stimulation can decrease the risk for disease progression as well as the need for and complexity of medications in patients with early-stage Parkinson disease compared with optimal medical therapy alone.

Moreover, advances in electrode design of deep brain stimulation devices for Parkinson’s disease is also expected to aid in growth of the market. Use of high-resolution electrodes, thin-film technology, and other advances may allow the development of multi-contact electrodes, which can even be flexible if required.

Market Trends

Deep brain stimulation devices for Parkinson’s disease are vulnerable to electromagnetic interference. In May 2018, a study published in the Journal of Neurosurgery, researchers noted that deep brain stimulation devices used to treat neurological movement disorders such as Parkinson’s disease, are vulnerable to strong electromagnetic fields that are created by other electrical devices.

R&D in deep brain stimulation is expected to boost growth of the global deep brain stimulation devices market for Parkinson’s disease. For instance, in June 2020, the study, “The structural connectivity of subthalamic deep brain stimulation correlates with impulsivity in Parkinson’s,” published in the journal Brain, reported that distinct connections between nerve cells in the brain may explain the reason behind Parkinson’s disease patients developing impulsivity and behavioral problems after deep brain stimulation therapy.

Figure 2. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Share, By Product, 2020

Deep Brain Stimulation Devices  | Coherent Market Insights

Key Takeaways of the Graph:

  • Among product, the dual-channel held dominant position in the market and accounted for 31.8% share in the global deep brain stimulation devices market for Parkinson’s disease in 2020. The segment is expected to reach US$ 2,001.2 million in 2028.
  • The growth in the segment can be attributed to new studies focused on dual channel deep brain stimulation system. For instance, based on a 2020 research study published in the Korean Movement Disorder Society compared the single and dual channel deep brain stimulation system. In the study, it was concluded that dual channel systems such as SceneRay, G102 and G102R enabled increased access to neurologists for evaluating and treating Parkinson’s disease.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Restraints

Excise tax on medical devices is expected to hinder growth of the global deep brain stimulation devices market for Parkinson’s disease. According to the Affordable Care Act in the U.S., an excise tax of 2.3% is imposed on importers and manufacturers of medical devices. This rise in cost is subsequently passed on to end customers that include patients seeking deep brain stimulation devices for Parkinson’s disease.

Moreover, use of deep brain stimulation is limited to highly refractory patients and conditions, typically in the context of expert multidisciplinary care and clinical research, which is also expected to limit the market growth.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Competitive Landscape

Major players operating in the global deep brain stimulation devices market for Parkinson’s disease include, Boston Scientific Corporation, MEDTRONIC, Inc., St Jude Medical, Inc., Sapiens Neuro, and Aleva Neurotherapeutics SA.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Key Developments

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in December 2019, Aleva Neurotherapeutics received CE Mark for its flagship product, the directSTIMTM Deep Brain Stimulation System.

Deep Brain Stimulation (DBS) is a treatment for Parkinson’s disease. It is a minimally invasive medical procedure which involves implanting thin copper electrodes into the cerebral cortex, which deliver electric impulses which either obstruct or alter the abnormal activity which result in Parkinson’s disease. DBS won't cure your disease, but it may help lessen your symptoms.

Market Dynamics:

Approval and launch of new devices is expected to propel growth of the global deep brain stimulation devices market for Parkinson’s disease. For instance, in July 2021, the U.S. Food and Drug Administration approved Activa RC and Activa PC, deep brain stimulation devices from Medtronic Plc.

Moreover, availability of at home DBS setting is also expected to aid in growth of the global deep brain stimulation devices market for Parkinson’s disease. For instance, in June 2021, a research from University of Florida, supported by the National Institute of Nursing Research of the National Institutes of Health, demonstrated a proof of concept that could help make DBS therapy more accessible to people who are unable to travel to academic health centers or large cities where the treatment is typically available.

 Key features of the study:

  • This report provides in-depth analysis of the global deep brain stimulation devices market for Parkinson’s disease, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global deep brain stimulation devices market for Parkinson’s disease based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Boston Scientific Corporation, MEDTRONIC, Inc., St Jude Medical, Inc., Sapiens Neuro, and Aleva Neurotherapeutics SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global deep brain stimulation devices market for Parkinson’s disease report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global deep brain stimulation devices market for Parkinson’s disease

Detailed Segmentation:

  • Global Brain Stimulation Devices Market for Parkinson’s Disease, By Product:
    • Single Channel
    • Dual-Channel
  • Global Brain Stimulation Devices Market for Parkinson’s Disease, By Region:
    • North America
      • By Product
        • Single Channel
        • Dual-Channel
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product
        • Single Channel
        • Dual-Channel
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product
        • Single Channel
        • Dual-Channel
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product
        • Single Channel
        • Dual-Channel
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product
        • Single Channel
        • Dual-Channel
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product
        • Single Channel
        • Dual-Channel
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Boston Scientific Corporation*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • MEDTRONIC, Inc.
    • St Jude Medical, Inc.
    • Sapiens Neuro
    • Aleva Neurotherapeutics SA

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • Regulatory Scenario
    • PEST Analysis
    • Mergers and Acquisitions
  4. Global Brain Stimulation Devices Market for Parkinson’s Disease, By Product, 2020 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Single Channel
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Dual-Channel
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
  5. Global Brain Stimulation Devices Market for Parkinson’s Disease, By Region, 2020 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2028
    • North America
      • Market Size and Forecast, By Product, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  6. Competitive Landscape
    • Company Profiles
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • MEDTRONIC, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • St Jude Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sapiens Neuro
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Aleva Neurotherapeutics SA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 21 market data tables and 23 figures on “Brain Stimulation Devices Market for Parkinson’s Disease - Global forecast to 2028”.

FAQgrowicon

Frequently Asked Questions

Global deep brain stimulation devices market for Parkinson’s disease size is estimated to be valued at US$ 3,567.6 Million in 2021 and is expected to exhibit a CAGR of 8.3% between 2021 and 2028.
Increasing prevalence of Parkinson’s disease and increasing geriatric population are the factors fueling growth of the market.
The dual-channel segment is the leading product segment in the market.
Excise tax on medical devices and use of deep brain stimulation limited to highly refractory patients and conditions, typically in the context of expert multidisciplinary care and clinical research are factors hindering growth of the market.
Major players operating in the market include, Boston Scientific Corporation, MEDTRONIC, Inc., St Jude Medical, Inc., Sapiens Neuro, and Aleva Neurotherapeutics SA
North America region is expected to hold dominant position in the market over the forecast period. The growth of the market in the region is driven by large target population base, new product approvals and extensive R&D activities.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.